You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
The IN.PACT™ Admiral™ drug-coated balloon (DCB) is a clinically proven, primary endovascular therapy that treats femoropopliteal disease, reduces reinterventions, and preserves future treatment options.1 The IN.PACT Admiral DCB is indicated for de novo, restenotic, or in-stent restenotic lesions up to 360 mm with reference vessel diameters of 4 to 7 mm in the superficial femoral or popliteal arteries.
Understand why the Medtronic paclitaxel-coated PTCA balloon is an effective treatment option for in-stent restenosis, de novo lesions, and small vessels. 3Product Details
Laird J. IN.PACT SFA 5-year Results. Presented at VIVA 2018; Las Vegas, NV.
Results from the IN.PACT AV Access Clinical Trial found in the IN.PACT AV drug-coated balloon (DCB) Instructions For Use (IFU).
Prevail Instructions for Use